No Data
Biocytogen Pharmaceuticals Announces 2024 AGM and Key Resolutions
BIOCYTOGEN-B: 2024 Annual Report
Interview with Dr. Shen Yuele, CEO of Bai'ao Saishu: The era of self-sustaining 2.0 is coming.
Recently, Bai Ao Sai Tu released its 2024 Earnings Reports, presenting a response that counters the trend: the company's revenue reached 0.98 billion yuan, an increase of approximately 36.8% compared to the same period last year; Net income was 33.54 million yuan, successfully turning losses into profits. This report, referred to by the Capital Markets as a "turning year," quickly attracted market attention, with the company’s stock price having risen a cumulative 79.3% this year (data as of the market close on March 27, 2025), significantly outperforming the Hang Seng index during the same period. Behind the impressive data lies the precise implementation of Global Strategy and the gradual rise of technological barriers. In the Global Biomedical Industry, there is a deep adjustment.
Baidu Bayesian-B (02315): Earnings performance exceeded expectations, driving a new round of value reassessment.
As the performance reaches a profitability turning point, the subsequent valuation increase of Bai Ao Sai Tu has become a highly probable event, warranting more attention from the market.
Understand at a glance | Highlights of Baiao Saitu's 2024 annual performance.
Source: Bai'ao Saitou.
Bai'ao Saitou-B (02315.HK) has impressive performance in 2024: revenue surged by 36.8%, with accelerated global pharmaceutical collaboration.
On March 26, Glorious Holdings announced its annual performance for Bai Aosai Tu-B (02315.HK). In the fiscal year 2024, the group achieved revenue of 0.9805 billion yuan, continuing rapid growth with an increase of approximately 36.8% compared to the same period last year; net income reached 33.5 million yuan, achieving a turnaround from loss to profit year-on-year; net inflow of cash from operating activities was 0.2112 billion yuan. The fiscal year 2024 is a milestone year for the company, achieving a turnaround to profit for the full year based on positive operating cash flow in the first half of the year. The successful completion of the profit turnaround goal marks the group's Global Strategy adjustment and.
meowmeow66 : I dont think moomoo can order this IPO. you can ask customer service to double check.